Connect to other sites within the UBM Medica Network
The sodium glucose cotransporter-2 inhibitors are the newest diabetes drugs available. Have you got the basic concepts under your belt? Try these 6 questions and find out.
Type 2 Diabetes in a 76-Year-Old Man: Which Drug to Add On?
John is an active older man whose A1c has gone from 6.8% to 7.6% since his last follow-up visit. He refuses to get involved in any “needle business.” What’s next?
SGLT2 Inhibitor Q & A
Four questions for you to answer, four facts you need to know.
Healthy Diet Trims Diabetes Risk in Minority Women
The risk is lowered more in minority women than in white women with a healthy diet, which can play a vital role in prevention.
Truths About HbA1c
In the international diabetes community the topic of hemoglobin A1c (HbA1c) continues to generate controversy for a number of reasons.
Diabetes Control Too Tight for Some Older Adults
Maintaining tight glycemic control in older diabetic adults who are in poor health can do far more harm than good, according to results of a new study.
Diabetes and GI Woes
Three-quarters of persons with diabetes will experience significant gastrointestinal symptoms. What underlies the evolution of these GI ailments?
Statins Urged for Diabetes to Curb Heart Disease
Recommendations from the American Diabetes Association also suggest a less stringent diastolic blood pressure target, all in keeping with recent changes in cardiovascular risk management guidelines.
Five Top Papers From 2014 That Will Impact Your Practice
New drugs that treat stubborn illness seen often in primary care lead this group of Top 5 Papers for 2014. Type 2 diabetes, cryptogenic stroke, and hep-C are key targets.
By clicking Accept, you agree to become a member of the UBM Medica Community.